Clever Culture Systems Past Earnings Performance
Past criteria checks 0/6
Clever Culture Systems's earnings have been declining at an average annual rate of -25.4%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 39% per year.
Key information
-25.4%
Earnings growth rate
-8.9%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | 39.0% |
| Return on equity | -154.4% |
| Net Margin | -297.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Should Shareholders Reconsider LBT Innovations Limited's (ASX:LBT) CEO Compensation Package?
Nov 23
Is LBT Innovations (ASX:LBT) Using Debt Sensibly?
Sep 09Is LBT Innovations (ASX:LBT) Using Debt In A Risky Way?
Sep 15Is LBT Innovations (ASX:LBT) Using Too Much Debt?
May 04How Much Is LBT Innovations Limited (ASX:LBT) Paying Its CEO?
Jan 04Revenue & Expenses Breakdown
How Clever Culture Systems makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -4 | 5 | 1 |
| 31 Mar 24 | 2 | -13 | 4 | 0 |
| 31 Dec 23 | 2 | -21 | 4 | 0 |
| 30 Sep 23 | 2 | -22 | 4 | 0 |
| 30 Jun 23 | 2 | -23 | 5 | 0 |
| 31 Mar 23 | 2 | -14 | 5 | 0 |
| 31 Dec 22 | 3 | -6 | 6 | 0 |
| 30 Sep 22 | 2 | -6 | 6 | 0 |
| 30 Jun 22 | 2 | -7 | 5 | 0 |
| 31 Mar 22 | 2 | -7 | 5 | 0 |
| 31 Dec 21 | 1 | -8 | 5 | 0 |
| 30 Sep 21 | 1 | -8 | 5 | 0 |
| 30 Jun 21 | 1 | -7 | 5 | 0 |
| 31 Mar 21 | 1 | -7 | 5 | 0 |
| 31 Dec 20 | 1 | -6 | 4 | 0 |
| 30 Sep 20 | 0 | -6 | 4 | 0 |
| 30 Jun 20 | 0 | -6 | 4 | 0 |
| 31 Mar 20 | 0 | -6 | 4 | 0 |
| 31 Dec 19 | 0 | -6 | 3 | 0 |
| 30 Sep 19 | 0 | -5 | 3 | 0 |
| 30 Jun 19 | 0 | -4 | 2 | 0 |
| 31 Mar 19 | 3 | -4 | 3 | 0 |
| 31 Dec 18 | 6 | -3 | 3 | 0 |
| 30 Sep 18 | 6 | -3 | 3 | 0 |
| 30 Jun 18 | 6 | -3 | 3 | 0 |
| 31 Mar 18 | 6 | -4 | 3 | 0 |
| 31 Dec 17 | 5 | -6 | 2 | 0 |
| 30 Sep 17 | 6 | -6 | 2 | 0 |
| 30 Jun 17 | 6 | -5 | 2 | 0 |
| 31 Mar 17 | 4 | -2 | 2 | 0 |
| 31 Dec 16 | 3 | 0 | 1 | 0 |
| 30 Sep 16 | 5 | 2 | 1 | 0 |
| 30 Jun 16 | 8 | 4 | 2 | 0 |
| 31 Mar 16 | 7 | 3 | 1 | 0 |
| 31 Dec 15 | 6 | 3 | 1 | 0 |
| 30 Sep 15 | 4 | 2 | 1 | 0 |
| 30 Jun 15 | 2 | 0 | 1 | 0 |
| 31 Mar 15 | 3 | 0 | 1 | 0 |
| 31 Dec 14 | 3 | 0 | 1 | 0 |
| 30 Sep 14 | 4 | 0 | 1 | 0 |
| 30 Jun 14 | 4 | 0 | 2 | 0 |
| 31 Mar 14 | 5 | 1 | 2 | 0 |
| 31 Dec 13 | 6 | 2 | 2 | 0 |
Quality Earnings: CC5 is currently unprofitable.
Growing Profit Margin: CC5 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CC5 is unprofitable, and losses have increased over the past 5 years at a rate of 25.4% per year.
Accelerating Growth: Unable to compare CC5's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CC5 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).
Return on Equity
High ROE: CC5 has a negative Return on Equity (-154.35%), as it is currently unprofitable.